This compound is primarily used in the pharmaceutical industry as an intermediate in the synthesis of chiral drugs. Its structure, featuring a chiral center and protected amino group, makes it valuable for constructing complex molecules, particularly those targeting specific biological pathways. It is often employed in the development of active pharmaceutical ingredients (APIs) for drugs treating conditions like infections or inflammatory diseases, leveraging its dichlorophenyl group for enhanced binding affinity. Additionally, its tert-butoxycarbonyl (Boc) protecting group allows for selective reactions in multi-step synthetic processes, ensuring precise molecular assembly.